Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ofichem Group logo — Family-owned CDMO and pharmaceutical supplier

Ofichem Group

Family-owned CDMO and pharmaceutical supplier

Founded 1975 The Netherlands The Netherlands 54 employees Manufacturing, Pharmaceutical

General Information

Company Name Ofichem Group
Founded Year 1975
Location The Netherlands The Netherlands
Employees 54
Industries Manufacturing, Pharmaceutical
Business Model B2B, D2C
Revenue Model Service Fee, Product Sales, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Ofichem Group. To contact Ofichem Group, visit ofichem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 23, 2026

Ofichem Group is highlighting their expert's insights ahead of CPHI Milan, an event taking place in 2026, demonstrating their participation in the related industry discussions.

Regulatory Approval Sep 22, 2026

Ofichem Group's Drug Product Manufacturing project achieved market approval in September 2026, highlighting their effective technical transfer process.

Get alerts when Ofichem Group shows new signals

About Ofichem Group

Ofichem Group, founded in 1975, is a seasoned player in the Manufacturing and Pharmaceutical industries, headquartered in The Netherlands. As a family-owned CDMO and pharmaceutical supplier, the company has built its reputation on more than five decades of GMP-certified expertise.

Renowned for its client-centric approach, Ofichem offers flexible and reliable solutions tailored to meet the unique needs of pharmaceutical teams. Their emphasis on clear, fast, and supportive service underscores their commitment to stand by their clients, ensuring every solution exceeds basic standards.

This established firm's steadfast presence in the European market, combined with its client-centered philosophy, makes it a compelling prospect for investors seeking stability and trust in the pharmaceutical sector. Currently, Ofichem Group has not disclosed any recent investments, suggesting untapped opportunities for growth with the right financial partnership.

Taxonomy: CDMO, Pharmaceutical Supplier, GMP-certified, API Manufacturing, API Sourcing, API Distribution, Formulation Development, Analytical Services, Drug Substance, Drug Product, Flexible Supply Solutions, Custom Solutions, Pharmaceutical Support, Experience-Based Guidance, Client-Centric Approach

Services & Products

Drug Substance Development
API Manufacturing Services
Drug Substance Analytical Services
Drug Product Manufacturing
Drug Product Analytical Services
Repacking Services

Target Customers

Pharmaceutical Companies Biotechnology Firms Research Institutions

No funding data available for Ofichem Group yet.

Ofichem Group Alternatives & Competitors

View All Alternatives
Ofichem Group vs
Grand River Aseptic Manufacturing
Grand River Aseptic Manufacturing United States

A leading CDMO delivering aseptic fill-finish services of liquid vials, lyophilized vials, syringes,...

Series C
429 employees
Biopharma, Biotechnology
Ofichem Group vs
Catalent
Catalent United States

more products. better treatments. reliably supplied. ™

Post-IPO Debt
12614 employees
Biotechnology, Manufacturing
Ofichem Group vs
Midas Pharma
Midas Pharma Germany

Trust. Expertise. Added Value.

282 employees
Biotechnology, Manufacturing
View all alternatives

FAQ About Ofichem Group

Family-owned CDMO and pharmaceutical supplier
Ofichem Group was founded in 1975.
Ofichem Group is headquartered in The Netherlands.
Ofichem Group operates in Manufacturing and Pharmaceutical. Its work centres on CDMO, Pharmaceutical Supplier, GMP-certified and API Manufacturing. Its customers include Pharmaceutical Companies, Biotechnology Firms and Research Institutions.
Ofichem Group has a B2B and D2C business model. Its revenue comes from Service Fee, Product Sales and Consulting Fee.
Ofichem Group has approximately 54 employees.
Ofichem Group offers: Drug Substance Development, API Manufacturing Services, Drug Substance Analytical Services, Drug Product Manufacturing, Drug Product Analytical Services, Repacking Services.
Top alternatives and competitors to Ofichem Group include Grand River Aseptic Manufacturing, Catalent, Midas Pharma, Avra Laboratories Pvt Ltd, AustinPx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ofichem Group and Grand River Aseptic Manufacturing are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ofichem Group, https://bouncewatch.com/company/ofichem-group, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes